Glytec announced today that it introduced the latest version of its eGlycemic Management System (eGMS) for managing insulin. Waltham, Mass.-based Glytec’s eGMS is centered around the FDA-cleared Glucommander algorithm, which leverages real-time and historical data to recommend insulin dosing by learning each patient’s insulin sensitivity and anticipating future needs, leading to a personalized treatment regime […]
Business/Financial News
Pyxis Oncology closes $152M Series B
Biologics developer Pyxis Oncology announced today that it closed a Series B financing round worth $152 million. Cambridge, Mass.-based Pyxis had its financing round co-led by Arix Bioscience and RTW Investments. Existing investors including Leaps by Bayer, Longwood Fund, Agent Capital and Ipsen also contributed to the $152 million, which brings Pyxis’ total funding to […]
Valeo Pharma signs Canadian commercialization deal with Novartis
Valeo Pharma announced today that it entered into a commercialization and supply agreement with Novartis Canada for its asthma therapies. Montreal-based Valeo’s deal is to offer Canadian commercialization efforts for two asthma therapies: Enerzair Breezhaler (indacaterol as acetate, glycopyrronium as bromide and mometasone furoate, and Atectura Breezhaler (indacaterol as acetate and mometasone fuorate). Under the […]
Diomics, Bonne Santé Group enter strategic alliance
Diomics and Bonne Santé Group announced today that they entered into a strategic alliance to develop a line of Diocare products. San Diego-based Diomics and Miami-based Bonne Santé Group, which operated through its Bonne Santé Natural Manufacturing division, entered the agreement in an effor tto develop, launch and distribute the Diocare products formulated to address […]
Vaxess Technologies raises $2M for its silk-based vaccine delivery through the skin
Vaxess Technologies today filed an SEC Form D to confirm the sale of $2 million in debt, options, warrants or other rights to buy securities. According to the filing, three investors contributed to the new notice offering, which made its first sale on Monday, March 22, 2021, before reaching its total offering amount of $2 […]
Gyroscope Therapeutics raises $148M Series C
Gyroscope Therapeutics announced today that it raised $148 million (£107.8 million) in a Series C financing round. Forbion’s Growth Opportunities Fund led the round, while Sofinnova Investments, funds and accounts advised by T. Rowe Price, Tetragon Financial, Fosun Pharma, Cambridge Innovation Capital and Syncona, along with an undisclosed fund, contributed. In conjunction with the financing, […]
How 5G could affect medtech
The latest standard of broadband technology continues to make waves in 2021. But what about medtech? Cellphone using 5G (Imagy by Frederik Lipfert on Unsplash) Wireless tech companies such as Qualcomm are predicting download speeds as high as 10 gigabits per second as next-generation 5G cellular networks roll out worldwide. The open question in medtech is […]
Dexcom promotes Jereme Sylvain to CFO
Dexcom (NASDAQ: DXCM) announced today that it has promoted Jereme Sylvain to become a new EVP and CFO at the continuous glucose monitoring company. Sylvain — who joined Dexcom in 2018 and was most recently SVP of finance and chief accounting officer — will report to COO Quentin Blackford. Previously, Blackford had been serving as […]
Eyenovia partners with Eversana to commercialize pupil dilation agent
Eyenovia (NSDQ:EYEN) announced today that it partnered with Eversana to help commercialize MydCombi if it earns U.S. approval. MydCombi is a fixed-combination mydriatic agent for potential use in comprehensive eye exams with a formulation for touchless fixed-combination microdosing in an effort to improve the patient experience. The FDA earlier this month accepted Eyenovia’s New Drug […]
Research indicates notable future growth in transdermal patch market
Research published today has highlighted potential growth down the line in the transdermal drug delivery patch space. Kuick Research published an analysis claiming that the U.S. transdermal patch drug market is revolving on account of two powerful “mega-trends.” Those trends — acceleration in the U.S. pharmaceutical market growth and the restructuring of the healthcare sector […]